Ali Moussa MD has Hematology/oncology as his primary medical specialty. Their primary office is: 12697 E 51st St in Tulsa, Oklahoma.
They're a part of the: Oklahoma Cancer Specialists And Research Institute, Llc medical group which has around 49 members. You can call their office at 918-505-3200 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1994 (around 30 years of experience). They are listed as doing telehealth appointments.
Ali Moussa MD
Oklahoma Cancer Specialists And Research Institute, Llc
12697 E 51st St
Tulsa, Oklahoma 74146
918-505-3200
Phone: 918-505-3200
Enter a starting address:
Additional Medical Specialties Include:
MEDICAL ONCOLOGY
Medical School: Sorry, his university is not listed
Graduation Year: 1994
The Primary Medical Specialty for Ali Moussa MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 9335182385
NPI #: 1548207814
NPI Created On: 06/02/2006
NPI Last Updated Listed as: 09/02/2020
Primary Taxonomy Code: 207RH0003X
License Number:
21439
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English, Arabic, ARABIC, ENGLISH.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788367059
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 818923335
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: CYRAMZA
Open Associated Drug #1: 0002-7669-01
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: RETEVMO
Associated Drug #2: 0002-2980-60
Payments Total: $25
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 832194975
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: PADCEV
Open Associated Drug #1: 51144-030-01
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 832195085
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: ADCETRIS
Open Associated Drug #1: 51144-050-01
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 832195129
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: PADCEV
Open Associated Drug #1: 51144-030-01
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 832195221
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: ADCETRIS
Open Associated Drug #1: 51144-050-01
Payments Total: $18
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783522129
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Hematology
Name of Drug #1: REBLOZYL
Open Associated Drug #1: 59572-711-01
Payments Total: $22
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783522245
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $22
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783522163
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $17
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783699341
Being Disputed:: No
Product Related: Yes
12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc
8801 S 101st E Ave
Tulsa, OK
Genesiscare Landmark Oklahoma Cancer Care Pc
6600 S Yale Ave
Tulsa, OK
Warren Clinic Inc
6161 S Yale Ave
Tulsa, OK
Saint Francis Hospital, Inc.
12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc
12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc
901 N Strong Blvd
Mcalester Ok 74501-4206
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
800 W Boise Cir
Broken Arrow Ok 74012-4974
Oklahoma Cancer Specialists And Research Institute, Llc
Dermatology
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Medical Oncology
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
3470 E Frank Phillips Blvd
Bartlesville Ok 74006-2406
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
View all 49 members of Oklahoma Cancer Specialists And Research Institute, Llc medical group